Grace Science

About:

Grace Science is a developer of small molecule inhibitors of NGLY1 to treat various forms of cancer.

Website: https://www.gracescience.com

Description:

Grace Science is a developer of small molecule inhibitors of NGLY1 to treat various forms of cancer.

Total Funding Amount:

$7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Founders:

Kristen Wilsey, Matt Wilsey

Number of Employees:

1-10

Last Funding Date:

2017-02-11

IPO Status:

Private

Industries: